As of 2024-12-13, the EV/EBITDA ratio of Paratek Pharmaceuticals Inc (PRTK) is -7.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTK's latest enterprise value is 343.47 mil USD. PRTK's TTM EBITDA according to its financial statements is -44.39 mil USD. Dividing these 2 quantities gives us the above PRTK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 10.0x | 8.6x |
| Forward P/E multiples | 13.2x - 19.1x | 16.2x |
| Fair Price | (13.97) - (11.47) | (13.38) |
| Upside | -726.4% - -614.6% | -700.1% |
| Date | EV/EBITDA |